CDH2 and breast carcinoma: Moreover, N-cadherin contributes to induce a mesenchymal-scattered phenotype associated with reduced E- and P-cadherin levels in squamous cell carcinoma and to promote breast cancer cell migration, invasion and metastasis[26-30].